Abstract The Alzheimer's Association and National Institutes of Health have emphasized the
need for participation of racial/ethnic populations in Alzheimer disease (AD) clinical …

Background: Racial/ethnic minorities have among the highest risks for Alzheimer disease
and dementia, but remain underrepresented in clinical research studies. Objective: To …

Purpose Recruitment and retention of US ethnic groups traditionally underrepresented in
research continues to pose challenges. The Michigan Center for Contextual Factors in …

Despite an increasing awareness of the problem, clinical research continues to include
lesser numbers of ethnic minority participants disproportionate to their population …

Abstract Background/Aims: The recruitment of culturally diverse subject populations into
research studies, particularly African-Americans (AA), has been the focus of intense interest …

Clinical Alzheimer's disease (AD) trials currently face a critical shortfall of thousands of
eligible participants, which inflates the duration and cost of the clinical study as well as …

Introduction Alzheimer's disease and related dementias (ADRD) disproportionately impact
racial and ethnic minority and socioeconomically disadvantaged adults. Yet, these …

African Americans experience higher incidence and prevalence of Alzheimer's disease
(AD). Yet, they continue to be underrepresented in AD research, limiting the ability to …

We describe the history, development, and success of the recruitment and screening
procedures used by researchers at the University of California, Davis Alzheimer's Disease …

Abstract The Washington University School of Medicine Knight Alzheimer Disease Research
Center's “African American Participation in Alzheimer Disease Research: Effective …